Abstract
Hemolyzed specimens continue to cost the laboratory time and money. However, the core laboratory at Georgia Regents Health System, Inc. has instituted a novel approach to managing this problem. The purpose of this study was to determine whether the laboratory's new approach had a significant impact on the turn-around time (TAT) and cost of processing hemolyzed and non-hemolyzed specimens in the laboratory. The investigators queried the laboratory information systems for hemolyzed and non-hemolyzed specimens categorized as routine or STAT from the core laboratory and calculated statistical differences between the groups with respect to TAT and cost.The investigators found a statistically significant difference in the time it takes to process STAT hemolyzed specimens versus non-hemolyzed specimens with the new approach. Because of the new approach, hemolyzed specimens were actually processed as fast as, or faster than non-hemolyzed specimens in the core laboratory.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 153-157 |
| Number of pages | 5 |
| Journal | Clinical laboratory science : journal of the American Society for Medical Technology |
| Volume | 26 |
| Issue number | 3 |
| State | Published - Jun 1 2013 |
Fingerprint
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
A novel approach to managing hemolyzed specimens. / Pretlow, Lester G; Johnson, Shamala; Russell, Barbara Landis; Evans, Bridget.
In: Clinical laboratory science : journal of the American Society for Medical Technology, Vol. 26, No. 3, 01.06.2013, p. 153-157.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A novel approach to managing hemolyzed specimens.
AU - Pretlow, Lester G
AU - Johnson, Shamala
AU - Russell, Barbara Landis
AU - Evans, Bridget
PY - 2013/6/1
Y1 - 2013/6/1
N2 - Hemolyzed specimens continue to cost the laboratory time and money. However, the core laboratory at Georgia Regents Health System, Inc. has instituted a novel approach to managing this problem. The purpose of this study was to determine whether the laboratory's new approach had a significant impact on the turn-around time (TAT) and cost of processing hemolyzed and non-hemolyzed specimens in the laboratory. The investigators queried the laboratory information systems for hemolyzed and non-hemolyzed specimens categorized as routine or STAT from the core laboratory and calculated statistical differences between the groups with respect to TAT and cost.The investigators found a statistically significant difference in the time it takes to process STAT hemolyzed specimens versus non-hemolyzed specimens with the new approach. Because of the new approach, hemolyzed specimens were actually processed as fast as, or faster than non-hemolyzed specimens in the core laboratory.
AB - Hemolyzed specimens continue to cost the laboratory time and money. However, the core laboratory at Georgia Regents Health System, Inc. has instituted a novel approach to managing this problem. The purpose of this study was to determine whether the laboratory's new approach had a significant impact on the turn-around time (TAT) and cost of processing hemolyzed and non-hemolyzed specimens in the laboratory. The investigators queried the laboratory information systems for hemolyzed and non-hemolyzed specimens categorized as routine or STAT from the core laboratory and calculated statistical differences between the groups with respect to TAT and cost.The investigators found a statistically significant difference in the time it takes to process STAT hemolyzed specimens versus non-hemolyzed specimens with the new approach. Because of the new approach, hemolyzed specimens were actually processed as fast as, or faster than non-hemolyzed specimens in the core laboratory.
UR - http://www.scopus.com/inward/record.url?scp=84883771079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883771079&partnerID=8YFLogxK
M3 - Article
C2 - 23967544
AN - SCOPUS:84883771079
VL - 26
SP - 153
EP - 157
JO - Journal of Medical Technology
JF - Journal of Medical Technology
SN - 0894-959X
IS - 3
ER -